These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Prostaglandin E1 in erectile dysfunction]. Porst H Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258 [TBL] [Abstract][Full Text] [Related]
47. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction. Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275 [TBL] [Abstract][Full Text] [Related]
48. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1]. Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934 [TBL] [Abstract][Full Text] [Related]
49. Long-term intracavernous self-injection with prostaglandin E1 for the treatment of erectile dysfunction. Canale D; Giorgi PM; Lencioni R; Morelli G; Gasperi M; Macchia E Int J Androl; 1996 Feb; 19(1):28-32. PubMed ID: 8698535 [TBL] [Abstract][Full Text] [Related]
50. [Intracavernous injection of vasoactive drugs for treating erectile impotence]. Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019 [TBL] [Abstract][Full Text] [Related]
51. [The interest of early rehabilitation with intracavernous injections following complete prostatectomy]. Amar E Presse Med; 2005 Jul; 34(13 Suppl):15-8. PubMed ID: 16158024 [TBL] [Abstract][Full Text] [Related]
52. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction. Montorsi F; Guazzoni G; Bergamaschi F; Ferini-Strambi L; Barbieri L; Rigatti P J Urol; 1993 May; 149(5 Pt 2):1291-5. PubMed ID: 7683061 [TBL] [Abstract][Full Text] [Related]
53. Intracavernous self-injection therapy for the treatment of erectile dysfunction. Chiang HS; Wen TC; Wu CC; Chiang WH J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391 [TBL] [Abstract][Full Text] [Related]
54. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection]. Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609 [TBL] [Abstract][Full Text] [Related]
55. [Initial experiences with prostaglandin E1 and PGE1 prepared injections]. Mattarelli G; Leibundgut B Helv Chir Acta; 1991 Sep; 58(3):335-7. PubMed ID: 1769856 [TBL] [Abstract][Full Text] [Related]
56. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections. Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130 [TBL] [Abstract][Full Text] [Related]
57. Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction. Lea AP; Bryson HM; Balfour JA Drugs Aging; 1996 Jan; 8(1):56-74. PubMed ID: 8785470 [TBL] [Abstract][Full Text] [Related]